LQT6283LB In-line leucoreduction system for red cell concentrates with LCRD2 Leucoflex soft filter 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 MacoPharma Australia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2016-RN-01573-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2016-12-13
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Macopharma was informed of a number of fast filtrations for reference npt6280la that includes the lcrd2 filter. this has led to some instances of ineffective filtration through the media of the lcrd2 filter. the frequency has increased to an average of 100 dpm (defect per million) (0.01%) on production from the month of june 2016. this sporadic defect is linked to a partial absence of the weld in the media caused by poor positioning (fold or gap) of the last polyester layer in the mattress. this defect is easily detectable during the initial stages of filtration by the presence of blood moving into the downstream chamber (exit side of filter) and tubing at the central point of the filter during priming. this leads to a very quick filtration.
  • 조치
    Macopharma is advising customers that they should pay particular attention to the priming of the filter. Unaffected filters may continue to be used. All priming faults (direct passage) must be discarded and should be returned to Macopharma Australia for analysis. Macopharma will supply a credit note for the loss of affected product. This action has been closed out on 16 June 2017.

Device

  • 모델명 / 제조번호(시리얼번호)
    LQT6283LB In-line leucoreduction system for red cell concentrates with LCRD2 Leucoflex soft filterARTG Number: 142856
  • Manufacturer

Manufacturer